Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Related Articles by Review for PubMed (Select 15735013)

1.

Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.

Liu S, Shen T, Huynh L, Klisovic MI, Rush LJ, Ford JL, Yu J, Becknell B, Li Y, Liu C, Vukosavljevic T, Whitman SP, Chang KS, Byrd JC, Perrotti D, Plass C, Marcucci G.

Cancer Res. 2005 Feb 15;65(4):1277-84.

2.

Role of RUNX family members in transcriptional repression and gene silencing.

Durst KL, Hiebert SW.

Oncogene. 2004 May 24;23(24):4220-4. Review.

PMID:
15156176
3.

The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.

Asou N.

Crit Rev Oncol Hematol. 2003 Feb;45(2):129-50. Review. Erratum in: Crit Rev Oncol Hematol. 2006 Oct;60(1):87.

PMID:
12604126
4.

Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.

Lutterbach B, Hiebert SW.

Gene. 2000 Mar 21;245(2):223-35. Review.

PMID:
10717473
5.

Core binding factor genes and human leukemia.

Hart SM, Foroni L.

Haematologica. 2002 Dec;87(12):1307-23. Review.

6.

Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.

Yang G, Khalaf W, van de Locht L, Jansen JH, van der Reijden BA, Müller-Tidow C, Delwel HR, Serve H, Clapp DW, Hiebert SW.

Ann Hematol. 2004 Jun;83(6):329-30. Epub 2004 Mar 30. Review.

PMID:
15052372
7.

Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.

Ganly P, Walker LC, Morris CM.

Leuk Lymphoma. 2004 Jan;45(1):1-10. Review.

PMID:
15061191
8.

Epigenetic targets in hematopoietic malignancies.

Claus R, Lübbert M.

Oncogene. 2003 Sep 29;22(42):6489-96. Review.

PMID:
14528273
9.

Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.

Osato M.

Oncogene. 2004 May 24;23(24):4284-96. Review.

PMID:
15156185
10.

Point mutations of the RUNx1/AML1 gene in sporadic and familial myeloid leukemias.

Osato M, Yanagida M, Shigesada K, Ito Y.

Int J Hematol. 2001 Oct;74(3):245-51. Review.

PMID:
11721958
11.

The ETO (MTG8) gene family.

Davis JN, McGhee L, Meyers S.

Gene. 2003 Jan 16;303:1-10. Review.

PMID:
12559562
12.

RUNX1-MTG16 fusion gene in acute myeloblastic leukemia with t(16;21)(q24;q22): case report and review of the literature.

De Braekeleer E, Douet-Guilbert N, Le Bris MJ, Morel F, Férec C, De Braekeleer M.

Cancer Genet Cytogenet. 2008 Aug;185(1):47-50. doi: 10.1016/j.cancergencyto.2008.04.011. Review.

PMID:
18656694
13.

Runx1/AML1 in normal and abnormal hematopoiesis.

Yamagata T, Maki K, Mitani K.

Int J Hematol. 2005 Jul;82(1):1-8. Review.

PMID:
16105753
14.

[Mechanism of leukemogenesis induced by AML 1-MTG 8].

Kitabayashi I, Ohki M.

Tanpakushitsu Kakusan Koso. 2000 Jan;45(1):26-32. Review. Japanese. No abstract available.

PMID:
10643332
15.

Runx1/AML-1 ranks as a master regulator of adult hematopoiesis.

Ichikawa M, Asai T, Chiba S, Kurokawa M, Ogawa S.

Cell Cycle. 2004 Jun;3(6):722-4. Epub 2004 Jun 28. Review.

16.

Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11.

Shigesada K, van de Sluis B, Liu PP.

Oncogene. 2004 May 24;23(24):4297-307. Review.

PMID:
15156186
17.

The Runx genes: lineage-specific oncogenes and tumor suppressors.

Cameron ER, Neil JC.

Oncogene. 2004 May 24;23(24):4308-14. Review.

PMID:
15156187
18.
19.

Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins.

Hiebert SW, Lutterbach B, Amann J.

Curr Opin Hematol. 2001 Jul;8(4):197-200. Review.

PMID:
11561155
20.

SLC22A4 and RUNX1: identification of RA susceptible genes.

Yamada R, Tokuhiro S, Chang X, Yamamoto K.

J Mol Med (Berl). 2004 Sep;82(9):558-64. Epub 2004 Jun 4. Review.

PMID:
15184985
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk